Arvanil and anandamide up-regulate CD36 expression in human peripheral blood mononuclear cells

Immunol Lett. 2007 Apr 15;109(2):145-54. doi: 10.1016/j.imlet.2007.02.004. Epub 2007 Mar 5.

Abstract

In this study we analysed the regulation of gene expression by arvanil and anandamide in human peripheral blood mononuclear cells (PBMCs) to clarify their immunosuppressive properties. PBMCs were activated, leading to CD36 down regulation, that was normalized by arvanil and anandamide. We used microarray technology to identify a regulatory pattern associated with cell proliferation in the presence of both substances. CD3-CD28 stimulated PBMCs showed a pattern of up-regulated and down-regulated genes after treatment with these substances. We selected and analysed several genes chosen by their function in the regulation of cell proliferation. We showed a transcriptional control of the CD36 gene by arvanil and anandamide associated with an increased protein expression, thus suggesting a possible role of CD36 in anandamide and arvanil anti-inflammatory pattern.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Arachidonic Acids / immunology
  • Arachidonic Acids / pharmacology*
  • CD28 Antigens / immunology
  • CD3 Complex / immunology
  • CD36 Antigens / biosynthesis*
  • CD36 Antigens / blood
  • CD36 Antigens / immunology
  • Capsaicin / analogs & derivatives*
  • Capsaicin / immunology
  • Capsaicin / pharmacology
  • Endocannabinoids
  • Humans
  • Leukocytes, Mononuclear / drug effects*
  • Leukocytes, Mononuclear / immunology
  • Lymphocyte Activation / drug effects
  • Oligonucleotide Array Sequence Analysis / methods
  • Polyunsaturated Alkamides / immunology
  • Polyunsaturated Alkamides / pharmacology*
  • Up-Regulation / drug effects

Substances

  • Arachidonic Acids
  • CD28 Antigens
  • CD3 Complex
  • CD36 Antigens
  • Endocannabinoids
  • Polyunsaturated Alkamides
  • arvanil
  • Capsaicin
  • anandamide